-
Data, models and systemsValue in health new
Perioperative enfortumab vedotin and pembrolizumab in cisplatin-ineligible bladder cancer
In a Markov model, perioperative enfortumab vedotin plus pembrolizumab cost $72,460 per QALY gained versus radical cystectomy alone.
Peer-reviewed -
Health todayCancer refines
HPV-attributable fraction in oropharyngeal cancer rose in seven countries over a decade
Central testing of 6,043 head and neck cancer specimens found HPV attributability in oropharyngeal cancer rose in all seven countries.
Peer-reviewed -
Health todayCancer refines
Smoking status and survival across solid cancers in a Finnish two-hospital cohort
Five-year overall survival was 71% in never smokers, 58% in former smokers and 49% in current smokers.
Peer-reviewed -
Health todayCancer refines
Depression recorded after cancer diagnosis and suicide risk in 755,079 South Korean adults
Cancer patients with no prior depression who were later diagnosed with it had a suicide hazard 4.76 times that of those without.
Peer-reviewed -
Data, models and systemsValue in health new
Enzalutamide in prostate cancer costs AUD$835,580 per QALY in ENZAMET trial analysis
Adding enzalutamide in the ENZAMET trial cost AUD$835,580 per QALY gained, far above the AUD$50,000 threshold.
Peer-reviewed -
Health todayCancer refines
Smaller colorectal tumours linked to nodal metastasis risk and worse survival in subgroups
In 10,513 colorectal cancer patients, smaller tumour diameter raised predicted lymph node metastasis risk and, below 3 cm, mortality.
Peer-reviewed -
Health todayCancer confirms
Cervical cancer screening rises but gaps persist in US medical records, 2019-2024
Screening rates rose in all racial and ethnic groups from 2019 to 2024, with the largest gain among Hispanic patients.
Peer-reviewed -
Health todayCancer new
Cancer in Japanese adults aged 85 and over rose more than four-fold between 1995 and 2020
Registry data show cancer cases in the oldest-old rising 5.9% a year, reaching 15.7% of all Japanese cases by 2020.
Peer-reviewed -
Behavioural scienceSmoking and vaping refines
Digital outreach on lung screening eligibility reached 11% of invitees in North Carolina
Of 26,909 adults invited by patient portal or text, 11% completed lung screening eligibility questions within 16 weeks, with lower reach among Black and Hispanic patients.
Peer-reviewed -
Health todayCancer refines
Three in five women aged 30-49 have never had cervical screening
Three in five women aged 30-49 worldwide have never been screened for cervical cancer, and 92% have never had an HPV test.
Peer-reviewed -
Health todayCancer refines
Cancer cachexia episodes coincide with disease progression and lower survival
In 52,236 patients with cancer, cachectic weight loss episodes occurred at times of disease progression, were linked to lower survival, and were more common in tumours with TP53 mutations.
Peer-reviewed -
Behavioural scienceInfection and pandemics new
Higher HPV antibody levels are associated with greater vaccine efficacy across types
A Bayesian meta-analysis of randomised HPV vaccine trials found higher type-specific antibody levels associated with greater efficacy against infection and CIN2+, with the level associated with protection differing by type.
Preprint · not peer-reviewed